In Focus

Joint statement on the current epidemics of new Coronavirus

Together with IPOPI, INGID, APSID, ASID, ARAPID, CIS, LASID, SEAPID we have worked on... es

PID Survey update - COVID-19

The Survey summary on COVID-19 in PID patients can be viewed  here. es

IPOPI – ESID Joint Statement: The use of monoclonal antibody treatment for patients with PID in the context of the COVID-19 pandemic

 IPOPI ESID Statement IPOPI – ESID Joint Statement The use of monoclonal antib... es
News

Hyper IgM Grant opportunity

ESID is pleased to announce an excellent grant funding opportunity es

X-Linked Carrier Survey is now open

The Hyper IgM Foundation and the Wiskott-Aldrich Foundation’s first-ever&nb... es

Independent study:SARS-CoV-2 infection in patients with GATA2 deficiency

es
Events
Shortcuts
Affiliated Societies
Affiliated Societies es
Gothenburg 2022
ESID 2022 Biennial meeting in Gothenburg es
Congress
ESID 2021: The Clinical Working Party Multidisciplinary Symposium es
Registry
ESID Online Registry es
Newsletter
Access ESID’s latest news es